Uric acid and hypertension

Daniel I. Feig, Duk Hee Kang, Takahiko Nakagawa, Marilda Mazzali, Richard J. Johnson

Research output: Contribution to journalArticlepeer-review

71 Scopus citations

Abstract

Epidemiologic studies published during the past 3 years support the possible role of uric acid in the onset of essential hypertension. Data from several large, longitudinal cardiovascular disease studies indicate that elevated serum uric acid is a predictor of incident hypertension and blood pressure progression. In a pediatric study, more than 90% of children with essential hypertension have serum uric acid levels above 5.5 mg/dL. During the same period, laboratory studies have provided compelling mechanistic evidence to explain the clinical observations. Uric acid causes hypertension in a rat model through the activation of the renin-angiotensin system, downregulation of nitric oxide, and induction of endothelial dysfunction and vascular smooth muscle proliferation. Ongoing clinical trials will elucidate the role of uric acid in human hypertension and will determine whether control of uric acid may be a new way to prevent or treat essential hypertension.

Original languageEnglish
Pages (from-to)111-115
Number of pages5
JournalCurrent Hypertension Reports
Volume8
Issue number2
DOIs
StatePublished - May 2006

Fingerprint

Dive into the research topics of 'Uric acid and hypertension'. Together they form a unique fingerprint.

Cite this